Breast cancer Clinical Trials
Recruiting breast cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat breast cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting breast cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting breast cancer trials
Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer
Developing and Testing the Efficacy of AI-Chatbot-Based
EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors
Multi-4SCAR-T Therapy Targeting Breast Cancer
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
Early Intervention
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Strategies to Decentralize Breast Ultrasound in Rwanda
Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer
Optimizing Functional Recovery After Breast Cancer Treatment
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery
ORASIS in Breast Reconstruction
Evaluation of the Safety and Efficacy of Single-Port Robot-Assisted Endoscopic Breast-Conserving Surgery and Nipple-sparing Matectomy With Reconstruction in Early-Stage Breast Cancer Patients
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
Percutaneous Cryoablation for the Treatment of Breast Cancer
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)
Breast and Cervical Cancer Stigma in Rwanda
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surgery
DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations
Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .
Overcoming Racial Disparities in Screening Mammography
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Researching the Effect of Exercise on Cancer
Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial
Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening Visits
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer
Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast Cancer
An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBC
Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer
An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
HER2 Vaccine for Locally Advanced Breast Cancer
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
Precision Supplemental Imaging in Women With Dense Breasts
REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial.
Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA)
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
Increasing Breast and Colorectal Cancer Screening in the Community
Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance Tool
JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer
Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
CBD for Breast Cancer Primary Tumors
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer
New trials in Boston, MA?
Pick a condition and we'll email you once a week when a new study starts recruiting in Boston, MA. Unsubscribe anytime.
Breast cancer clinical trials — common questions
Are breast cancer clinical trials free to join?
Yes. Participating in a breast cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a breast cancer clinical trial?
Each breast cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a breast cancer trial near me?
Use the location controls above. We'll show recruiting breast cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many breast cancer trials are recruiting right now?
We're currently tracking roughly 708 recruiting breast cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.